strange, page-4

it's a biotech thing. Of the biotechs i follow... PXS, AVX, AAH. ACR, NEU and BTA, all are rated as having good prospects by analysts and yet all went down or remained steady today (actually, i think AAH might have gone up a cent). This isn't about Avexa, its about the market and the market is not interested in biotechs right now. Like Tana said, the only thing that will change that is news from management about a deal to fund phase 3 or a takeover. No point fretting over AVX moving up or down a few cents and wondering what it all means - it means nothing.